US Stock MarketDetailed Quotes

DRMAW DERMATA THERAPEUTICS INC C/WTS (TO PUR COM)

Watchlist
  • 0.0147
  • 0.00000.00%
Close Jul 19 16:00 ET
0Market Cap0.00P/E (TTM)

DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-46.00%4.73M
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
-35.99%8.07M
2,387.79%10.63M
-Cash and cash equivalents
-46.00%4.73M
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
-35.99%8.07M
2,387.79%10.63M
Receivables
----
-33.69%8.36K
-33.69%8.36K
-99.41%76
--790
--6.36K
--12.6K
--12.6K
--12.89K
----
-Accrued interest receivable
----
-33.69%8.36K
-33.69%8.36K
-99.41%76
--790
--6.36K
--12.6K
--12.6K
--12.89K
----
Prepaid assets
-21.13%347.92K
-23.76%517.65K
-23.76%517.65K
-22.85%662.58K
-37.94%212.93K
-25.79%441.12K
-11.75%678.99K
-11.75%678.99K
-20.66%858.76K
1,436.25%343.11K
Current deferred assets
----
----
----
----
----
----
----
----
--0
--0
Other current assets
21.38%98.16K
24.94%14.5K
24.94%14.5K
-19.67%29.25K
9.36%60.63K
2.28%80.87K
--11.6K
--11.6K
--36.41K
481.60%55.44K
Total current assets
-44.27%5.18M
14.89%7.98M
14.89%7.98M
-18.40%7.32M
-20.98%8.71M
2.78%9.3M
-40.26%6.94M
-40.26%6.94M
-34.42%8.97M
869.90%11.03M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-44.27%5.18M
14.89%7.98M
14.89%7.98M
-18.40%7.32M
-20.98%8.71M
2.78%9.3M
-40.26%6.94M
-40.26%6.94M
-34.42%8.97M
869.90%11.03M
Liabilities
Current liabilities
Payables
66.89%822.55K
74.36%866.03K
74.36%866.03K
-1.92%474.46K
-28.09%437.78K
-25.57%492.87K
-3.60%496.7K
-3.60%496.7K
-37.17%483.74K
-30.92%608.81K
-accounts payable
66.89%822.55K
74.36%866.03K
74.36%866.03K
-1.92%474.46K
-28.09%437.78K
-25.57%492.87K
-3.60%496.7K
-3.60%496.7K
-37.17%483.74K
-30.92%608.81K
Current accrued expenses
-45.38%318.41K
-83.92%41.1K
-83.92%41.1K
-82.51%113.31K
-86.28%63.12K
83.09%582.91K
8.56%255.54K
8.56%255.54K
80,883.38%647.87K
-21.59%459.89K
Current liabilities
13.65%1.37M
75.98%1.62M
75.98%1.62M
-39.05%916.82K
-50.03%682.86K
1.30%1.21M
-39.17%922.63K
-39.17%922.63K
25.86%1.5M
-16.81%1.37M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
13.65%1.37M
75.98%1.62M
75.98%1.62M
-39.05%916.82K
-50.03%682.86K
1.30%1.21M
-39.17%922.63K
-39.17%922.63K
25.86%1.5M
-16.81%1.37M
Shareholders'equity
Share capital
178.66%666
410.39%393
410.39%393
-73.64%319
-68.42%319
-71.31%239
-90.76%77
-90.76%77
45.26%1.21K
-86.42%1.01K
-common stock
178.66%666
410.39%393
410.39%393
-73.64%319
-68.42%319
-71.31%239
-90.76%77
-90.76%77
45.26%1.21K
428.80%1.01K
Retained earnings
-18.16%-56.52M
-17.10%-53.39M
-17.10%-53.39M
-16.69%-51.25M
-19.36%-49.53M
-23.38%-47.83M
-26.71%-45.59M
-26.71%-45.59M
-31.39%-43.92M
-30.84%-41.5M
Paid-in capital
7.88%60.33M
15.75%59.74M
15.75%59.74M
12.19%57.66M
12.52%57.56M
19.95%55.92M
11.99%51.61M
11.99%51.61M
11.92%51.39M
63.95%51.16M
Total stockholders'equity
-52.92%3.81M
5.53%6.36M
5.53%6.36M
-14.24%6.41M
-16.87%8.03M
3.00%8.09M
-40.42%6.02M
-40.42%6.02M
-83.73%7.47M
2,009.83%9.66M
Total equity
-52.92%3.81M
5.53%6.36M
5.53%6.36M
-14.24%6.41M
-16.87%8.03M
3.00%8.09M
-40.42%6.02M
-40.42%6.02M
-40.19%7.47M
2,009.83%9.66M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -46.00%4.73M19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M-35.99%8.07M2,387.79%10.63M
-Cash and cash equivalents -46.00%4.73M19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M-35.99%8.07M2,387.79%10.63M
Receivables -----33.69%8.36K-33.69%8.36K-99.41%76--790--6.36K--12.6K--12.6K--12.89K----
-Accrued interest receivable -----33.69%8.36K-33.69%8.36K-99.41%76--790--6.36K--12.6K--12.6K--12.89K----
Prepaid assets -21.13%347.92K-23.76%517.65K-23.76%517.65K-22.85%662.58K-37.94%212.93K-25.79%441.12K-11.75%678.99K-11.75%678.99K-20.66%858.76K1,436.25%343.11K
Current deferred assets ----------------------------------0--0
Other current assets 21.38%98.16K24.94%14.5K24.94%14.5K-19.67%29.25K9.36%60.63K2.28%80.87K--11.6K--11.6K--36.41K481.60%55.44K
Total current assets -44.27%5.18M14.89%7.98M14.89%7.98M-18.40%7.32M-20.98%8.71M2.78%9.3M-40.26%6.94M-40.26%6.94M-34.42%8.97M869.90%11.03M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -44.27%5.18M14.89%7.98M14.89%7.98M-18.40%7.32M-20.98%8.71M2.78%9.3M-40.26%6.94M-40.26%6.94M-34.42%8.97M869.90%11.03M
Liabilities
Current liabilities
Payables 66.89%822.55K74.36%866.03K74.36%866.03K-1.92%474.46K-28.09%437.78K-25.57%492.87K-3.60%496.7K-3.60%496.7K-37.17%483.74K-30.92%608.81K
-accounts payable 66.89%822.55K74.36%866.03K74.36%866.03K-1.92%474.46K-28.09%437.78K-25.57%492.87K-3.60%496.7K-3.60%496.7K-37.17%483.74K-30.92%608.81K
Current accrued expenses -45.38%318.41K-83.92%41.1K-83.92%41.1K-82.51%113.31K-86.28%63.12K83.09%582.91K8.56%255.54K8.56%255.54K80,883.38%647.87K-21.59%459.89K
Current liabilities 13.65%1.37M75.98%1.62M75.98%1.62M-39.05%916.82K-50.03%682.86K1.30%1.21M-39.17%922.63K-39.17%922.63K25.86%1.5M-16.81%1.37M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 13.65%1.37M75.98%1.62M75.98%1.62M-39.05%916.82K-50.03%682.86K1.30%1.21M-39.17%922.63K-39.17%922.63K25.86%1.5M-16.81%1.37M
Shareholders'equity
Share capital 178.66%666410.39%393410.39%393-73.64%319-68.42%319-71.31%239-90.76%77-90.76%7745.26%1.21K-86.42%1.01K
-common stock 178.66%666410.39%393410.39%393-73.64%319-68.42%319-71.31%239-90.76%77-90.76%7745.26%1.21K428.80%1.01K
Retained earnings -18.16%-56.52M-17.10%-53.39M-17.10%-53.39M-16.69%-51.25M-19.36%-49.53M-23.38%-47.83M-26.71%-45.59M-26.71%-45.59M-31.39%-43.92M-30.84%-41.5M
Paid-in capital 7.88%60.33M15.75%59.74M15.75%59.74M12.19%57.66M12.52%57.56M19.95%55.92M11.99%51.61M11.99%51.61M11.92%51.39M63.95%51.16M
Total stockholders'equity -52.92%3.81M5.53%6.36M5.53%6.36M-14.24%6.41M-16.87%8.03M3.00%8.09M-40.42%6.02M-40.42%6.02M-83.73%7.47M2,009.83%9.66M
Total equity -52.92%3.81M5.53%6.36M5.53%6.36M-14.24%6.41M-16.87%8.03M3.00%8.09M-40.42%6.02M-40.42%6.02M-40.19%7.47M2,009.83%9.66M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg